Trial intelligence / Profile preview

R-CPOP as First-Line Therapy for Elderly or Cardiac-Impaired DLBCL

DRKS00000718Phase 2Terminated

Sponsor
Universitätsklinikum Freiburg
Start
Oct 2015
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
2
01

Overview

A Phase 2 trial of pixantrone in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Universitätsklinikum Freiburg. Started Oct 2015; status: terminated.

02

Drugs

pixantrone
03

Conditions

diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)

Beyond the preview

Go deeper on DRKS00000718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call